Purchase Order N3239817P0343
Award Date 7/11/17
Potential Completion Date 12/1/17
Potential Value $7.8K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC for the delivery of EZ1 DNA BLOOD 350 UL KITS (48). The contract has a ceiling value of $20,961.12 and a completion date of September 29, 2019. Qiagen, LLC is a division of the international provider of sample and assay technologies, Qiagen N.V. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
- This is a federal purchase order contract award to Qiagen, LLC, a division of Qiagen N.V., by the U.S. Department of Defense's Bureau of Medicine and Surgery. The contract is for the purchase of QIAAMP DNA BLOOD KIT, 200UL and EZ1 DNA TISSUE KIT, 200UL at a firm fixed price of $102,022.09. The award date was July 27, 2015, and the ultimate completion date is August 1, 2016. This contract has no set-aside designation. Qiagen is an international provider of sample and assay technologies that has...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and bioinformatics solutions. The contract has a ceiling value of $4,909.67 and a period of performance through April 11, 2025. The contract covers the "EXERCISE FULL AGREEMENT FOR EZ1 ADVANCED" requirement, which likely involves the provision of Qiagen's EZ1 DNA/RNA extraction equipment and...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of Qiagen N.V., for the provision of laboratory supplies. The contract has a ceiling value of $75,149.98 and a completion date of August 30, 2018. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic applications, and has previously supplied goods and services to various...
- This federal contract award from the Defense Health Agency (DHA) is for the procurement of EZ1 DNA BLOOD 350 UL KIT TO PURIFY BLOOD, a product offered by Qiagen, LLC, a foreign-owned, for-profit manufacturer. The $39,770.00 firm fixed-price purchase order does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has an extensive portfolio of federal contract awards and grant activities supporting biomedical research, public...
- This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Qiagen, LLC for a reagent kit needed to sequence libraries. The contract has a ceiling value of $22,607.27 and a completion date of September 30, 2024. Qiagen is a division of the international provider Qiagen N.V. and has extensive experience supporting federal agencies' biomedical research, public health, and healthcare programs through past prime and subcontract awards....
- This $83,927.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of EZ1 ADVANCED XL equipment, which is used for DNA/RNA extraction and sample preparation. This purchase order is not associated with a set-aside program. Qiagen has a history of providing specialized products and services to support...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $1,897 firm fixed-price purchase order is for labor hours (CLIN 9236439) with a period of performance through September 29, 2019. Qiagen is an established provider of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare...
- The U.S. federal government awarded a Firm Fixed Price Purchase Order contract worth $22,732.35 to Qiagen, LLC, a division of the international company Qiagen N.V., for the provision of DNA isolation kits. The contract has an ultimate completion date of June 1, 2018 and was awarded on May 3, 2018 by the Acquisitions agency, which is a civilian agency. Qiagen, LLC is a foreign-owned, for-profit manufacturer that has provided various products and services to support federal agencies' biomedical...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a subsidiary of Qiagen N.V., for QIAGEN KITS. The contract has a ceiling value of $8,390.82 and a performance period ending on September 12, 2014. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has supported various federal agencies' biomedical research, public health,...